{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:46:19Z","timestamp":1790171179543,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The overexpression of the protein tyrosine kinase, Focal adhesion kinase (FAK), in endothelial cells has implicated its requirement in angiogenesis and tumour growth, but how pericyte FAK regulates tumour angiogenesis is unknown. We show that pericyte FAK regulates tumour growth and angiogenesis in multiple mouse models of melanoma, lung carcinoma and pancreatic B-cell insulinoma and provide evidence that loss of pericyte FAK enhances Gas6-stimulated phosphorylation of the receptor tyrosine kinase, Axl with an upregulation of Cyr61, driving enhanced tumour growth. We further show that pericyte derived Cyr61 instructs tumour cells to elevate expression of the proangiogenic\/protumourigenic transmembrane receptor Tissue Factor. Finally, in human melanoma we show that when 50% or more tumour blood vessels are pericyte-FAK negative, melanoma patients are stratified into those with increased tumour size, enhanced blood vessel density and metastasis. Overall our data uncover a previously unknown mechanism of tumour growth by pericytes that is controlled by pericyte FAK.<\/jats:p>","DOI":"10.1038\/s41467-020-16618-6","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T06:03:02Z","timestamp":1591250582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pericyte FAK negatively regulates Gas6\/Axl signalling to suppress tumour angiogenesis and tumour growth"],"prefix":"10.1038","volume":"11","author":[{"given":"Tanguy","family":"Lechertier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-1808","authenticated-orcid":false,"given":"Louise E.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"G\u00f3mez-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mu\u00f1oz-F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Dukinfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fevzi","family":"Demircioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Pui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-7721","authenticated-orcid":false,"given":"Kylie P.","family":"Matchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-4094","authenticated-orcid":false,"given":"Neil C.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-8379","authenticated-orcid":false,"given":"Maddy","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-749X","authenticated-orcid":false,"given":"Kairbaan M.","family":"Hodivala-Dilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"16618_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","volume":"21","author":"A Armulik","year":"2011","unstructured":"Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193\u2013215 (2011).","journal-title":"Dev. Cell"},{"key":"16618_CR2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers, G. & Song, S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7, 452\u2013464 (2005).","journal-title":"Neuro Oncol."},{"key":"16618_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.trsl.2014.01.011","volume":"163","author":"A Geevarghese","year":"2014","unstructured":"Geevarghese, A. & Herman, I. M. Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl. Res. 163, 296\u2013306 (2014).","journal-title":"Transl. Res."},{"key":"16618_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","volume":"160","author":"S Morikawa","year":"2002","unstructured":"Morikawa, S. et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160, 985\u20131000 (2002).","journal-title":"Am. J. Pathol."},{"key":"16618_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gde.2010.10.008","volume":"21","author":"K De Bock","year":"2011","unstructured":"De Bock, K., Cauwenberghs, S. & Carmeliet, P. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications. Curr. Opin. Genet. Dev. 21, 73\u201379 (2011).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"16618_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/onc.2014.18","volume":"34","author":"C Rupp","year":"2015","unstructured":"Rupp, C. et al. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction. Oncogene 34, 815\u2013825 (2015).","journal-title":"Oncogene"},{"key":"16618_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","volume":"151","author":"V Luga","year":"2012","unstructured":"Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542\u20131556 (2012).","journal-title":"Cell"},{"key":"16618_CR8","doi-asserted-by":"publisher","first-page":"e101402","DOI":"10.1371\/journal.pone.0101402","volume":"9","author":"EM Caspani","year":"2014","unstructured":"Caspani, E. M., Crossley, P. H., Redondo-Garcia, C. & Martinez, S. Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes. PLoS ONE 9, e101402 (2014).","journal-title":"PLoS ONE"},{"key":"16618_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4049\/jimmunol.1300280","volume":"191","author":"A Bose","year":"2013","unstructured":"Bose, A. et al. Tumor-derived vascular pericytes anergize Th cells. J. Immunol. 191, 971\u2013981 (2013).","journal-title":"J. Immunol."},{"key":"16618_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrc3792","volume":"14","author":"FJ Sulzmaier","year":"2014","unstructured":"Sulzmaier, F. J., Jean, C. & Schlaepfer, D. D. FAK in cancer: mechanistic findings and clinical applications. Nat. Rev. Cancer 14, 598\u2013610 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"16618_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/path.3018","volume":"226","author":"T Lechertier","year":"2012","unstructured":"Lechertier, T. & Hodivala-Dilke, K. Focal adhesion kinase and tumour angiogenesis. J. Pathol. 226, 404\u2013412 (2012).","journal-title":"J. Pathol."},{"key":"16618_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1083\/jcb.200506184","volume":"172","author":"R Braren","year":"2006","unstructured":"Braren, R. et al. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 172, 151\u2013162 (2006).","journal-title":"J. Cell Biol."},{"key":"16618_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1083\/jcb.200411155","volume":"169","author":"TL Shen","year":"2005","unstructured":"Shen, T. L. et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J. Cell Biol. 169, 941\u2013952 (2005).","journal-title":"J. Cell Biol."},{"key":"16618_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbamcr.2004.04.008","volume":"1692","author":"DD Schlaepfer","year":"2004","unstructured":"Schlaepfer, D. D., Mitra, S. K. & Ilic, D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 1692, 77\u2013102 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"16618_CR15","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.1158\/0008-5472.CAN-10-2740","volume":"70","author":"J Lee","year":"2010","unstructured":"Lee, J., Borboa, A. K., Chun, H. B., Baird, A. & Eliceiri, B. P. Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma. Cancer Res. 70, 10131\u201310140 (2010).","journal-title":"Cancer Res."},{"key":"16618_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/emmm.201000106","volume":"2","author":"B Tavora","year":"2010","unstructured":"Tavora, B. et al. Endothelial FAK is required for tumour angiogenesis. EMBO Mol. Med 2, 516\u2013528 (2010).","journal-title":"EMBO Mol. Med"},{"key":"16618_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/315115a0","volume":"315","author":"D Hanahan","year":"1985","unstructured":"Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes. Nature 315, 115\u2013122 (1985).","journal-title":"Nature"},{"key":"16618_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1083\/jcb.153.3.543","volume":"153","author":"M Hellstrom","year":"2001","unstructured":"Hellstrom, M. et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543\u2013553 (2001).","journal-title":"J. Cell Biol."},{"key":"16618_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1017\/S1431927611012402","volume":"18","author":"AN Stratman","year":"2012","unstructured":"Stratman, A. N. & Davis, G. E. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc. Microanal. 18, 68\u201380 (2012).","journal-title":"Microsc. Microanal."},{"key":"16618_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"16618_CR21","doi-asserted-by":"publisher","first-page":"e7575","DOI":"10.1371\/journal.pone.0007575","volume":"4","author":"A Gustafsson","year":"2009","unstructured":"Gustafsson, A., Bostrom, A. K., Ljungberg, B., Axelson, H. & Dahlback, B. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS ONE 4, e7575 (2009).","journal-title":"PLoS ONE"},{"key":"16618_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10873-2","volume":"7","author":"R Kanzaki","year":"2017","unstructured":"Kanzaki, R. et al. Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy. Sci. Rep. 7, 10613 (2017).","journal-title":"Sci. Rep."},{"key":"16618_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nri2303","volume":"8","author":"G Lemke","year":"2008","unstructured":"Lemke, G. & Rothlin, C. V. Immunobiology of the TAM receptors. Nat. Rev. Immunol. 8, 327\u2013336 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"16618_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.0000074881.56564.46","volume":"92","author":"G Collett","year":"2003","unstructured":"Collett, G. et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ. Res. 92, 1123\u20131129 (2003).","journal-title":"Circ. Res."},{"key":"16618_CR25","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1093\/emboj\/17.20.5933","volume":"17","author":"DJ Sieg","year":"1998","unstructured":"Sieg, D. J. et al. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration. EMBO J. 17, 5933\u20135947 (1998).","journal-title":"EMBO J."},{"key":"16618_CR26","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.4161\/15384047.2014.956634","volume":"15","author":"K Penzes","year":"2014","unstructured":"Penzes, K. et al. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells. Cancer Biol. Ther. 15, 1571\u20131582 (2014).","journal-title":"Cancer Biol. Ther."},{"key":"16618_CR27","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nrd3599","volume":"10","author":"JI Jun","year":"2011","unstructured":"Jun, J. I. & Lau, L. F. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov. 10, 945\u2013963 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"16618_CR28","doi-asserted-by":"publisher","first-page":"46248","DOI":"10.1074\/jbc.M209288200","volume":"277","author":"SJ Leu","year":"2002","unstructured":"Leu, S. J., Lam, S. C. & Lau, L. F. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J. Biol. Chem. 277, 46248\u201346255 (2002).","journal-title":"J. Biol. Chem."},{"key":"16618_CR29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1089\/10430340260185094","volume":"13","author":"V Fataccioli","year":"2002","unstructured":"Fataccioli, V. et al. Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate. Hum. Gene Ther. 13, 1461\u20131470 (2002).","journal-title":"Hum. Gene Ther."},{"key":"16618_CR30","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.juro.2009.12.006","volume":"183","author":"KB D\u2019Antonio","year":"2010","unstructured":"D\u2019Antonio, K. B. et al. Extracellular matrix associated protein CYR61 is linked to prostate cancer development. J. Urol. 183, 1604\u20131610 (2010).","journal-title":"J. Urol."},{"key":"16618_CR31","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1172\/JCI67816","volume":"123","author":"J Schlegel","year":"2013","unstructured":"Schlegel, J. et al. MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J. Clin. Invest. 123, 2257\u20132267 (2013).","journal-title":"J. Clin. Invest."},{"key":"16618_CR32","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.18632\/oncotarget.2422","volume":"5","author":"H Axelrod","year":"2014","unstructured":"Axelrod, H. & Pienta, K. J. Axl as a mediator of cellular growth and survival. Oncotarget 5, 8818\u20138852 (2014).","journal-title":"Oncotarget"},{"key":"16618_CR33","doi-asserted-by":"publisher","first-page":"14187","DOI":"10.1074\/jbc.M009755200","volume":"276","author":"D Xie","year":"2001","unstructured":"Xie, D. et al. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J. Biol. Chem. 276, 14187\u201314194 (2001).","journal-title":"J. Biol. Chem."},{"key":"16618_CR34","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-05-0231","volume":"11","author":"S Gery","year":"2005","unstructured":"Gery, S. et al. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin. Cancer Res. 11, 7243\u20137254 (2005).","journal-title":"Clin. Cancer Res."},{"key":"16618_CR35","first-page":"5603","volume":"60","author":"MS Tsai","year":"2000","unstructured":"Tsai, M. S., Hornby, A. E., Lakins, J. & Lupu, R. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res. 60, 5603\u20135607 (2000).","journal-title":"Cancer Res."},{"key":"16618_CR36","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0049-3848(10)70010-4","volume":"125","author":"W Ruf","year":"2010","unstructured":"Ruf, W., Yokota, N. & Schaffner, F. Tissue factor in cancer progression and angiogenesis. Thromb. Res. 125, S36\u2013S38 (2010).","journal-title":"Thromb. Res."},{"key":"16618_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bjoms.2007.04.021","volume":"45","author":"EA Baker","year":"2007","unstructured":"Baker, E. A., Leaper, D. J., Hayter, J. P. & Dickenson, A. J. Plasminogen activator system in oral squamous cell carcinoma. Br. J. Oral Maxillofac. Surg. 45, 623\u2013627 (2007).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"16618_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1160\/TH05-01-0054","volume":"93","author":"K Dano","year":"2005","unstructured":"Dano, K. et al. Plasminogen activation and cancer. Thromb. Haemost. 93, 676\u2013681 (2005).","journal-title":"Thromb. Haemost."},{"key":"16618_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.devcel.2011.11.002","volume":"22","author":"XL Chen","year":"2012","unstructured":"Chen, X. L. et al. VEGF-induced vascular permeability is mediated by FAK. Dev. Cell 22, 146\u2013157 (2012).","journal-title":"Dev. Cell"},{"key":"16618_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.201307067","volume":"204","author":"C Jean","year":"2014","unstructured":"Jean, C. et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J. Cell Biol. 204, 247\u2013263 (2014).","journal-title":"J. Cell Biol."},{"key":"16618_CR41","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajh.21745","volume":"85","author":"A Raza","year":"2010","unstructured":"Raza, A., Franklin, M. J. & Dudek, A. Z. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am. J. Hematol. 85, 593\u2013598 (2010).","journal-title":"Am. J. Hematol."},{"key":"16618_CR42","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/cncr.25483","volume":"117","author":"X Song","year":"2011","unstructured":"Song, X. et al. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer 117, 734\u2013743 (2011).","journal-title":"Cancer"},{"key":"16618_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1158\/0008-5472.CAN-03-0245","volume":"64","author":"PR van Ginkel","year":"2004","unstructured":"van Ginkel, P. R. et al. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res. 64, 128\u2013134 (2004).","journal-title":"Cancer Res."},{"key":"16618_CR44","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1182\/blood-2003-11-3952","volume":"104","author":"JR Gothert","year":"2004","unstructured":"Gothert, J. R. et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104, 1769\u20131777 (2004).","journal-title":"Blood"},{"key":"16618_CR45","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1210\/en.2007-1415","volume":"149","author":"H Liu","year":"2008","unstructured":"Liu, H. et al. Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 149, 1666\u20131677 (2008).","journal-title":"Endocrinology"},{"key":"16618_CR46","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.bjc.6604712","volume":"99","author":"ZJ Sun","year":"2008","unstructured":"Sun, Z. J. et al. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br. J. Cancer 99, 1656\u20131667 (2008).","journal-title":"Br. J. Cancer"},{"key":"16618_CR47","doi-asserted-by":"publisher","first-page":"8663","DOI":"10.1073\/pnas.96.15.8663","volume":"96","author":"K Abe","year":"1999","unstructured":"Abe, K. et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Natl Acad. Sci. USA 96, 8663\u20138668 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16618_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nprot.2011.435","volume":"7","author":"M Baker","year":"2012","unstructured":"Baker, M. et al. Use of the mouse aortic ring assay to study angiogenesis. Nat. Protoc. 7, 89\u2013104 (2012).","journal-title":"Nat. Protoc."},{"key":"16618_CR49","first-page":"503","volume":"120","author":"LE Reynolds","year":"2006","unstructured":"Reynolds, L. E. & Hodivala-Dilke, K. M. Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol. Med. 120, 503\u2013509 (2006).","journal-title":"Methods Mol. Med."},{"key":"16618_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mvr.2012.03.008","volume":"84","author":"U Tigges","year":"2012","unstructured":"Tigges, U., Welser-Alves, J. V., Boroujerdi, A. & Milner, R. A novel and simple method for culturing pericytes from mouse brain. Microvasc. Res. 84, 74\u201380 (2012).","journal-title":"Microvasc. Res."},{"key":"16618_CR51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1242\/jcs.197848","volume":"130","author":"LE Reynolds","year":"2017","unstructured":"Reynolds, L. E. et al. Dual role of pericyte alpha6beta1-integrin in tumour blood vessels. J. Cell Sci. 130, 1583\u20131595 (2017).","journal-title":"J. Cell Sci."}],"updated-by":[{"DOI":"10.1038\/s41467-023-41239-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16618-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T18:55:39Z","timestamp":1722970539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16618-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16618"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16618-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-023-41239-0","URL":"https:\/\/doi.org\/10.1038\/s41467-023-41239-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2810"}}